COMPOUNDED PREPARATIONS WITH NYSTATIN FOR ORAL AND OROMUCOSAL ADMINISTRATION

被引:2
|
作者
Sklenar, Zbynek [1 ]
Scigel, Vladimir [2 ]
Horackova, Katerina [3 ]
Slanar, Ondrej [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Pharmacol, Prague 12800 2, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Inst Clin & Expt Dent Med, Prague 12800 2, Czech Republic
[3] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Analyt Chem, Prague 12800 2, Czech Republic
来源
ACTA POLONIAE PHARMACEUTICA | 2013年 / 70卷 / 04期
关键词
nystatin hydrogel; nystatin viscous suspension; nystatin oromucosal globule; extemporaneous compounding; compounded (magistral) preparations; candidiasis; pediatric therapy;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Therapy of oral, esophageal and gastrointestinal candidiasis is still a common problem that can be solved by an administration of antimycotics. Major disadvantage of registered commercial antifungal medicinal products is their price, so the health care system and its payers may profit from extemporaneous compounding. An appropriate drug therapy for candidiasis (trash) is nystatin, which is a substance available in the Czech Republic for the magistral preparation relatively recently, since 2010. Making formulas for extemporaneous compounding is quite simple and preparations particularly useful for dentists, pediatricians, otolaryngolgists, oncologists and gastroenterologists. The authors formulated composition of viscous oromucosal suspension, oral/oromucosal hydrogel and oromucosal gelatine globule which may be present as compounded products containing nystatin for oromucosal and/or oral administration. The preparation is practically verified and magistral products have been already used in clinical practice.
引用
收藏
页码:759 / 762
页数:4
相关论文
共 50 条
  • [2] CONCENTRATIONS OF NYSTATIN IN FECES AFTER ORAL-ADMINISTRATION OF VARIOUS DOSES OF NYSTATIN
    HOFSTRA, W
    DEVRIESHOSPERS, HG
    VANDERWAAIJ, D
    INFECTION, 1979, 7 (04) : 166 - 170
  • [3] Topical sirolimus: Difference between compounded preparations and commercial oral solution
    Brichta, Lars
    Carver, James G.
    Carver DeKlotz, Cynthia Marie
    PEDIATRIC DERMATOLOGY, 2021, 38 (04) : 967 - 969
  • [4] HEMATOGEN CONTACT-DERMATITIS BY ORAL-ADMINISTRATION OF NYSTATIN
    LECHNER, T
    GRYTZMANN, B
    BAURLE, G
    MYKOSEN, 1987, 30 (03): : 143 - 146
  • [5] Oral administration of pancreatic preparations.
    Lawrence, RD
    BRITISH MEDICAL JOURNAL, 1928, 1928 (01): : 875 - 875
  • [6] Preparations of ergot for oral administration.
    不详
    BRITISH MEDICAL JOURNAL, 1930, 1930 : 707 - 707
  • [7] Ergot preparations for oral administration.
    Wokes, F
    BRITISH MEDICAL JOURNAL, 1930, 1930 : 800 - 800
  • [8] Stability of Lansoprazole in Extemporaneously Compounded Suspensions for Nasogastric or Oral Administration
    Ensom, Mary H. H.
    Decarie, Diane
    Sheppard, Ian
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2007, 60 (03): : 184 - 191
  • [9] CONTRIBUTION TO THE MANUFACTURE OF NYSTATIN PREPARATIONS
    TORGAU, K
    PHARMAZIE, 1982, 37 (02): : 157 - 157
  • [10] Physicochemical Evaluation of Compounded Oral Preparations for Respiratory Illnesses, also known as Mezclitas
    Pozzi-Lorenzo, Vanessa G.
    Delgado-Martinez, Frances Y.
    Butler-Sanchez, Maralis
    Melin, Kyle
    Santiago-Quinones, Darlene, I
    PUERTO RICO HEALTH SCIENCES JOURNAL, 2020, 39 (02) : 189 - 194